Lalitha Prajna Selected Research

Lalitha Prajna Research Topics

15	Keratitis 11/2022 - 03/2005
6	Infections 11/2022 - 03/2005
4	Ulcer 10/2018 - 03/2013
3	Eye Infections 01/2021 - 10/2013
3	Mycoses (Diseases, Fungus) 01/2020 - 12/2016
2	Cataract (Cataracts) 01/2021 - 01/2013
2	Corneal Perforation 04/2013 - 06/2010
1	Coinfection 11/2022
1	Wounds and Injuries (Trauma) 01/2021
1	Abscess 01/2021
1	Endophthalmitis (Ophthalmia) 05/2020
1	Corneal Injuries 01/2020
1	Acanthamoeba Keratitis 01/2020
1	Canaliculitis 10/2015
1	Lacrimal Apparatus Diseases (Epiphora) 10/2015
1	Pseudomonas Infections 03/2014
1	Pharyngitis (Sore Throat) 10/2013
1	Edema (Dropsy) 09/2013
1	Atrophy 09/2013
1	Inflammation (Inflammations) 09/2013
1	Intraoperative Complications 01/2013
1	Cicatrix (Scar) 06/2010
1	Rubella (German Measles) 04/2004
1	Eye Abnormalities (Eye Abnormality) 04/2004

4	Anti-Bacterial Agents (Antibiotics)IBA 11/2022 - 03/2008
3	FluoroquinolonesIBA 11/2022 - 03/2013
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 12/2016
3	Natamycin (Pimaricin)FDA Link 01/2018 - 06/2010
2	tear proteinsIBA 01/2020 - 01/2017
2	Virulence Factors (Pathogenicity Factors)IBA 03/2017 - 03/2014
2	Voriconazole (Vfend)FDA LinkGeneric 04/2013 - 06/2010
1	HCEIBA 01/2022
1	Biocompatible Materials (Biomaterials)IBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 02/2020
1	chemotactic factor inactivatorIBA 01/2020
1	Complement System Proteins (Complement)IBA 01/2020
1	AminoglycosidesIBA 07/2019
1	Bacterial ToxinsIBA 10/2018
1	Ophthalmic Solutions (Eye Drops)IBA 01/2018
1	Amphotericin B (Amphotericin)FDA LinkGeneric 01/2018
1	Glycoproteins (Glycoprotein)IBA 01/2017
1	ChitraIBA 12/2016
1	ProteomeIBA 12/2016
1	homocysteine-thiolactone-nicotinamide (ST 22)IBA 03/2014
1	SuperantigensIBA 10/2013
1	Retinaldehyde (Retinal)IBA 09/2013
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 09/2013
1	SteroidsIBA 03/2013
1	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2013
1	Hypromellose DerivativesIBA 01/2013
1	Capsules (Microcapsules)IBA 01/2013
1	Immunoglobulin G (IgG)IBA 04/2004
1	AntibodiesIBA 04/2004